The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The objective of the study is to implement a new method of performing chest CT imaging in young children with cystic fibrosis at Packard Children's Hospital. This technique will be used to evaluate early lung disease comparing quantitative chest CT air trapping and airway measurements with lung function measurements in infants, toddlers, and young children with chronic lung disease.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
2 Months to 5 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Young children with cystic fibrosis at Packard Children's Hospital.
Infants and young children (age ~ 2/3 months to < 5 years)
Diagnosed with cystic fibrosis with either 2 identified CFTR gene mutations, or a positive sweat chloride
Informed consent by parent or legal guardian.
Ability to comply with study visit procedures as judged by the investigator.
Acute wheezing and/or respiratory distress at either study visit.
Acute intercurrent respiratory infection, defined as an increase in cough, wheezing, or respiratory rate with onset in 1 week preceding Study visit.
Oxygen saturation < 90% on room air at study visit.
Any medical condition that in the opinion of the investigator precludes subject participation.